Citation Impact
Citing Papers
Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin
2014
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Some New Perspectives in Heparin-Induced Thrombocytopenia Type II
2001
Platelet Count Monitoring and Laboratory Testing for Heparin-Induced Thrombocytopenia Recommendations of the College of American Pathologists
2002
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
Monitoring Sedation Status Over Time in ICU Patients
2003 Standout
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
A case for capnographic monitoring as a standard of care
1999
Heparin versus danaparoid in off-pump coronary bypass grafting: Results of a prospective randomized clinical trial
2003
Effect of Sedation With Dexmedetomidine vs Lorazepam on Acute Brain Dysfunction in Mechanically Ventilated Patients
2007 Standout
Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia
2001
Heparin-Protein Interactions
2002 Standout
Platelet Count Monitoring and Laboratory Testing for Heparin-Induced Thrombocytopenia
2002
Breath Analysis: Potential for Clinical Diagnosis and Exposure Assessment
2006
The impact of delirium in the intensive care unit on hospital length of stay
2001 Standout
Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin‐dependent antibodies
2005
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
High incidence of anti‐heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery
1998
Pediatric Heparin-Induced Thrombocytopenia: Prevalence, Thrombotic Risk, and Application of the 4Ts Scoring System
2014
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Laboratory Testing for Heparin-Induced Thrombocytopenia
2000
Cardiovascular Surgery Without Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia Type II Using Anticoagulation with Recombinant Hirudin
2000
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
2004
Conscious sedation in the emergency department: The value of capnography and pulse oximetry
1992
Heparin-Induced Thrombocytopenia Following Cardiac Surgery is Associated With Poor Outcome
2006
Point of care testing in the emergency department
2002
Delirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care Unit
2004 Standout
Heparin-Induced Thrombocytopenia
1998
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Critical review of non-invasive respiratory monitoring in medical care
2003
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
2006 Standout
Patients with a History of Type II Heparin-Induced Thrombocytopenia with Thrombosis Requiring Cardiac Surgery with Cardiopulmonary Bypass: A Prospective Observational Case Series
2003
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia
1999
Pharmacokinetics and Pharmacodynamics of Sedatives and Analgesics in the Treatment of Agitated Critically Ill Patients
1997
Risk factors for thrombosis in patients with immune mediated heparin‐induced thrombocytopenia
2002
A Novel Antidote-Controlled Anticoagulant Reduces Thrombin Generation and Inflammation and Improves Cardiac Function in Cardiopulmonary Bypass Surgery
2006
Aptamers as therapeutics
2010 Standout
Use of Plasma Exchange and Heparin During Cardiopulmonary Bypass for a Patient with Heparin Induced Thrombocytopenia: A Case Report
2001
Diagnostic score for heparin‐induced thrombocytopenia after cardiopulmonary bypass
2004
Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparin
2002
What is the potential for overdiagnosis of heparin‐induced thrombocytopenia?
2007
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings
2006 Standout
Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia
2018
Heparin-Induced Thrombocytopenia
2006 Standout
Frequency of Heparin‐Induced Thrombocytopenia in Critical Care Patients
2003
Prevention of Venous Thromboembolism
2004 Standout
Determination of heparin–platelet factor 4–IgG antibodies improves diagnosis of heparin‐induced thrombocytopenia
2001
Heparin-induced thrombocytopenia and cardiac surgery
2003 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Heparin-induced thrombocytopenia and cardiac surgery
2003
Safety of Warfarin Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Prevention of Venous Thromboembolism
2008 Standout
Estimation of respiratory volumes from the photoplethysmographic signal. Part I: experimental results
1999
Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support
2006
The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion
2010
CLINICAL APPLICATION OF ARGATROBAN AS AN ALTERNATIVE ANTICOAGULANT FOR EXTRACORPOREAL CIRCULATION
2000
Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery
2004
Photoplethysmography and its application in clinical physiological measurement
2007 Standout
Thrombocytopenia Associated with Antithrombotic Therapy in Patients with Cardiovascular Diseases
2008
Emergent Cardiopulmonary Bypass in Five Patients with Heparin-induced Thrombocytopenia Type II Employing Recombinant Hirudin
1998
Pump-seed synchronization for MHz repetition rate, high-power optical parametric chirped pulse amplification
2012 StandoutNobel
Sedation in the intensive care unit
2000
Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery
2003
Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: Confirmation in a prospective study
2012
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies
2000
Intraoperative anticoagulation management during cardiac transplantation for a patient with heparin-induced thrombocytopenia and a left ventricular assist device.
2008
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Sensitive Wearable Temperature Sensor with Seamless Monolithic Integration
2019 Standout
Patient Survival after Human Albumin Administration
2001
State-of-the-Art Review : Heparin-induced Thrombocytopenia and Thrombosis Syndrome
1998
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia
2004
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis After Intraoperative Heparin Anticoagulation
2006
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit
2004 Standout
Management of urgent high-risk cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and coexisting disorders of renal function: Use of heparin and epoprostenol combined with on-line monitoring of platelet function
2000
Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody
2002
Patients with a History of Type II Heparin-Induced Thrombocytopenia with Thrombosis Requiring Cardiac Surgery with Cardiopulmonary Bypass: A Prospective Observational Case Series
2003
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
2015
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Costs and Benefits of Health Information Technology
2006 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Colloids versus crystalloids for fluid resuscitation in critically ill patients
2013
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: A 1-year experience in 57 patients
2000
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
2005 Standout
Heparin-induced thrombocytopenia
2003
Cardiovascular Surgery Without Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia Type II Using Anticoagulation with Recombinant Hirudin
2000
Antibodies to Platelet Factor 4–Heparin After Cardiopulmonary Bypass in Patients Anticoagulated With Unfractionated Heparin or a Low-Molecular-Weight Heparin
1999
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Works of Stephen E. McNulty being referenced
The Effect of Midazolam and Lorazepam on Postoperative Recovery After Cardiac Surgery
1995
Relationship between arterial carbon dioxide and end-tidal carbon dioxide when a nasal sampling port is used
1990
Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery
2001
Evaluation of STAT-CRIT?? Hematocrit Determination in Comparison to Coulter and Centrifuge
1993
A Comparison of Four Bedside Methods of Hemoglobin Assessment During Cardiac Surgery
1995
An improved nasal prong apparatus for end-tidal carbon dioxide monitoring in awake, sedated patients
1991
A Comparison of Four Bedside Methods of Hemoglobin Assessment During Cardiac Surgery
1995
Prevalence of Heparin-Associated Antibodies Without Thrombosis in Patients Undergoing Cardiopulmonary Bypass Surgery
1997